Effective and safe treatment of a novel IL2RA deficiency with rapamycin

J Allergy Clin Immunol Pract. 2020 Mar;8(3):1132-1135.e4. doi: 10.1016/j.jaip.2019.09.027. Epub 2019 Oct 9.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Predisposition to Disease
  • Humans
  • Immunologic Deficiency Syndromes*
  • Interleukin-2 Receptor alpha Subunit / deficiency
  • Interleukin-2 Receptor alpha Subunit / genetics
  • Sirolimus* / therapeutic use

Substances

  • IL2RA protein, human
  • Interleukin-2 Receptor alpha Subunit
  • Sirolimus

Supplementary concepts

  • Interleukin 2 Receptor, Alpha, Deficiency of